I wouldn't discount the revenue value of Bio-t-Gel. Immediate revenue may not be great but the existing agreement is only for the United States. Teva currently employs approximately 47,000 people in over 60 countries and reached $16.1 billion in net sales in 2010. The global potential with a company like Teva is great.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.